Company / Goodwill
Celldex Therapeutics, Inc. Goodwill History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$91.0M
FY2017
5-year range
-
FY2016-FY2017
Trend
+0.0%
vs FY2016
Sector context
#108 of 136
Health Care
What the data says
Celldex Therapeutics, Inc.'s goodwill of $91M is lower than 79% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
$91M in FY2017.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 136This company $91.0M Sector average $5.2B
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2017, goodwill increased 0.0% year-over-year.
- Ranks #108 out of 136 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $91.0M | +0.0% |
| FY2016 | $91.0M | +914.8% |
As of FY2017 · SEC 10-K · Updated Jul 2, 2026